Fortress Biotech (FBIO) vs Heron Therapeutics (HRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Fortress Biotech (FBIO) has outperformed Heron Therapeutics (HRTX) over the past year, losing 33.1% versus a loss of 70.9%. Over five years, FBIO leads with a -95.6% price change compared with -96.4% for HRTX. Heron Therapeutics is the larger company by market cap ($69.9 million vs $68.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FBIO | HRTX |
|---|---|---|
| Share price | $2.07 | $0.3681 |
| Market cap | $68.87M | $69.88M |
| 1-day change | +1.23% | -4.22% |
| YTD return | -44.26% | -70.44% |
| 1-year return | -33.11% | -70.89% |
| 5-year return | -95.58% | -96.37% |
| P/E ratio (TTM) | 0.75 | — |
| EPS (TTM) | $2.76 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.53 | $1.58 |
| 52-week low | $2.00 | $0.26 |
| Distance from 52-week high | -54.42% | -76.70% |
| Average volume | 507.86K | 2.58M |
| Shares outstanding | 33.35M | 189.85M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FBIO has outperformed HRTX by 37.8 percentage points over the past year.
FBIO vs HRTX FAQ
Which is bigger, Fortress Biotech or Heron Therapeutics?
Heron Therapeutics (HRTX) is larger, with a market capitalization of $69.88M compared with $68.87M for Fortress Biotech (FBIO).
Which stock has performed better over the past year, FBIO or HRTX?
FBIO returned -33.11% over the past 12 months, compared with -70.89% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Are Fortress Biotech and Heron Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.